TrialThe British journal of dermatology2022

Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial.

D Thaçi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.